Samir N. Khleif, Georgia Health Sciences University (IMAGE)
Caption
Select patients with advanced prostate cancer may benefit from a Georgia Health Sciences University Cancer Center clinical trial, led by GHSU Cancer Center Director Samir N. Khleif, that looks to improve survival rates of the FDA-approved prostate cancer drug Provenge.
Credit
Phil Jones, Georgia Health Sciences University Photographer
Usage Restrictions
None
License
Licensed content